Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.130 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,125,904
Open 2.130
Bid (Size) 2.420 (19)
Ask (Size) 2.430 (28)
Prev. Close 2.130
Today's Range 2.130 - 2.130
52wk Range 0.5052 - 1.530
Shares Outstanding 52,571,813
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The trading volume of these stocks is deviating from the norm in today's session.
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
+97.2%
+97.2%
1 Month
+200.0%
+200.0%
3 Month
+164.6%
+164.6%
6 Month
+85.2%
+85.2%
1 Year
+47.9%
+47.9%

More News

Read More
These stocks are making the most noise in today's session.
Via Chartmill
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
An Overview of Spero Therapeutics's Earnings
Via Benzinga
A Glimpse of Spero Therapeutics's Earnings Potential
Via Benzinga
The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
Via Benzinga
Exposures Fossil Fuels
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
Via Benzinga
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
Via Benzinga
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled
Via Stocktwits
What 4 Analyst Ratings Have To Say About Spero Therapeutics
Via Benzinga
Spero Therapeutics's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
SPRO Stock Earnings: Spero Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
3 Micro-Cap Moonshots for Fearless Investors
Via InvestorPlace
SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Spero Therapeutics, Inc. - Common Stock publicly traded?
Yes, Spero Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Spero Therapeutics, Inc. - Common Stock trade on?
Spero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Spero Therapeutics, Inc. - Common Stock?
The ticker symbol for Spero Therapeutics, Inc. - Common Stock is SPRO on the Nasdaq Stock Market
What is the current price of Spero Therapeutics, Inc. - Common Stock?
The current price of Spero Therapeutics, Inc. - Common Stock is 2.130
When was Spero Therapeutics, Inc. - Common Stock last traded?
The last trade of Spero Therapeutics, Inc. - Common Stock was at 05/29/25 04:00 PM ET
What is the market capitalization of Spero Therapeutics, Inc. - Common Stock?
The market capitalization of Spero Therapeutics, Inc. - Common Stock is 111.98M
How many shares of Spero Therapeutics, Inc. - Common Stock are outstanding?
Spero Therapeutics, Inc. - Common Stock has 112M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.